898550-57-7

Upstream product

• 108-24-7 acetic anhydride 
• 898550-56-6 4,4',6'-tri(benzyloxy)-2'-hydroxy-3'-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)chalcone 
• 169566-46-5 1-(4,6-bis(benzyloxy)-2-hydroxy-3-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)ethanone 
• 4291-69-4 2,3,4,6-Tetra-O-benzyl-D-glucopyranose 
• 80300-30-7 1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose 
• 18065-05-9 1-[2,4-bis(benzyloxy)-6-hydroxyphenyl]ethanone 
• 1309438-45-6 4,6-bis-hydroxy-3-C-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-2-hydroxyacetophenone 
• 480-66-0 2,4,6-trihydroxyacetophenone 
• 100-39-0 benzyl bromide 
• 97-30-3 methyl D-glucopyranoside 
• 84799-77-9 methyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 
• 4397-53-9 p-benzyloxybenzaldehyde 

Downstream Products

• 66026-80-0 4′,7-dihydroxy-8β-D-glucose isoflavone 

Relevant academic research and scientific papers

Exploiting the therapeutic potential of 8-β- d -glucopyranosylgenistein: Synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42)

8-β-d-Glucopyranosylgenistein (1), the major component of Genista tenera, was synthesized and showed an extensive therapeutical impact in the treatment of STZ-induced diabetic rats, producing normalization of fasting hyperglycemia and amelioration of exce

Total synthesis of two isoflavone C-glycosides: genistein and orobol 8-C-β-d-glucopyranosides

Genistein and orobol 8-C-β-d-glucopyranosides (1 and 3) were firstly synthesized in overall yields of 39% and 41% from 2,4-di-O-benzylphloroacetophenone (4), as follows: (1) the formation of the chalcone (6, 7) by aldol condensation of the benzyl-protecte